Advertisement

The Nervous System

  • James A. Ferrante

Abstract

Patients do not present themselves to the family physician with neurologic diseases. They present with symptoms that may indicate neurologic impairment, but often the symptoms result from another underlying disease state or are psychological in origin. Even more common is the combination of neurologic disease, psychic distress, and underlying systemic illness. The family physician’s knowledge of the patient and his family is essential for a comprehensive neurologic evaluation of the presenting complaint. To proceed with an incomplete data base would be a disservice to the patient and inadequate care at best.

Keywords

Amyotrophic Lateral Sclerosis Family Physician Cluster Headache Essential Tremor Optic Neuritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Weiner HL, Levitt LP: Neurology for the House Officer, 2nd ed. Baltimore, Williams & Wilkins, 1978.Google Scholar
  2. 2.
    Samuels MA, Sargent RK: Neurologic emergencies. Patient Care 15 (9): 12–63, 1981.Google Scholar
  3. 3.
    Lubic LG, Palkovitz HP: Stroke: Discussion in Patient Management. Garden City, N.Y., Medical Examination, 1979.Google Scholar
  4. 4.
    Barnett HVM. Prevention of stroke. Am J Med 69: 803805, 1980.Google Scholar
  5. 5.
    Barnett HVM: The pathophysiology of transient cerebral ischemic attacks. Med Clin North Am 63(4):649679, 1979.Google Scholar
  6. 6.
    Soltero I, Liu K, Cooper R, Stamler J, Garside D: Trends in mortality from cerebrovascular diseases in the United States, 1969 to 1975. Stroke 9: 549–555, 1978.PubMedCrossRefGoogle Scholar
  7. 7.
    Kannel WB, Wolf P, Dewber TR: Hypertension and cardiac impairments increase stroke risk. Geriatrics 33: 71–83, 1979.Google Scholar
  8. 8.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effect of treatment on mor- 31. bidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 213: 1143–1152, 1970.CrossRefGoogle Scholar
  9. 9.
    Walker A, Robins M, Weinfeld F: The national survey of stroke. Clinical findings. Stroke 12 (2): 13–44, 1981.Google Scholar
  10. 10.
    Mohr VP: Transient ischemic attacks and the prevention of stroke. N Engl J Med 299: 93–95, 1978.PubMedCrossRefGoogle Scholar
  11. 11.
    Busuttil RW, Baker JD, Dairdson RK, Machleder HI: Carotid artery stenosis-hemodynamic significance and clinical course. JAMA 245: 1438–1441, 1981.PubMedCrossRefGoogle Scholar
  12. 12.
    Thompson JE, Garrett WV: Peripheral artery surgery. N Engl J Med 302: 491–503, 1980.PubMedCrossRefGoogle Scholar
  13. 13.
    Blaisdell WF, Glickman M, Trankey DD: Ulcerated atheroma of the carotid artery. Arch Surg 108: 491, 1974. 36.Google Scholar
  14. 14.
    Olsson JE, Brechter HB, Krook H, Miller R, Nitelius E, Olsson O, Tornberg A: Anticoagulant vs. antiplatelet therapy as prophylaxis against cerebral infarction in transient ischemic attacks. Stroke 11: 4–9, 1980.PubMedCrossRefGoogle Scholar
  15. 15.
    Millikan C: Anticoagulant treatment to prevent cerebral infarction. Med Clin North Am 63 (4): 897–904, 1979.PubMedGoogle Scholar
  16. 16.
    The Canadian Cooperative Study Group: A randomized trial of aspirin and sulfinpyrazone in treated stroke. N 40. Engl J Med 299: 53–59, 1978.CrossRefGoogle Scholar
  17. 17.
    Genton E, Barnett HVM, Fields W, Gent M, Hook J: Cerebral ischemia: the role of thrombosis and anti-thrombotic therapy. Stroke 8: 147–175, 1977.CrossRefGoogle Scholar
  18. 18.
    Jones HR, Millikan CH: Temporal profile (clinical course) of acute carotid system cerebral infarction. Stroke 7: 64–71, 1976.PubMedCrossRefGoogle Scholar
  19. 19.
    Adams HP, Jergenson D, Kassell N, Sahe AL: Pitfalls in the recognition of subarachnoid hemorrhage. JAMA 44. 244(8): 794–796, 1980.Google Scholar
  20. 20.
    Sundt TM, Whisnant JP: Subarachnoid hemorrhage from intracranial aneurysm. N Engl J Med 299: 116122, 1978.Google Scholar
  21. 21.
    Naidick TP, Moran CV, Pudlowski RM, Hanaway J: Advances in diagnosis: Cranial and spinal computed tomography. Med Clin North Am 63 (4): 849–895, 1979.Google Scholar
  22. 22.
    Isselbacher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JD: Principles of Internal Medicine. New York, McGraw-Hill, 1980.Google Scholar
  23. 23.
    Lehman JF, DeLateur BJ, Fowles RS: Stroke. Does rehabilitation affect outcome? Arch Phys Med and Rehabil 49. 56: 375, 1975.Google Scholar
  24. 24.
    Segal JL: Hypertensive emergencies: Practical approach to treatment. Postgrad Med 68 (2): 107–125, 1980.PubMedGoogle Scholar
  25. 25.
    Mroczek WJ, Davidov M, Gavrilovich L, et al.: The value of aggressive therapy in the hypertensive patient with 51. azotemia. Circulation 40: 893–904, 1969.PubMedCrossRefGoogle Scholar
  26. 26.
    Caviness VS, O’Brien P: Current concepts: Headache. N Engl J Med 302 (8): 446–450, 1980.PubMedCrossRefGoogle Scholar
  27. 27.
    Diamond S, Medina J: Headaches. Clin Symp 33: 2–9, 1981.Google Scholar
  28. 28.
    Saper JR: Migraine. Classification and pathogenesis. JAMA 239 (22): 2380–2383, 1978.PubMedCrossRefGoogle Scholar
  29. 29.
    Saper JR: Migraine. Treatment. JAMA 239(23):24802484, 1978.Google Scholar
  30. 30.
    Ziegler DK: Tension headache. Med Clin North Am 62: 495–505, 1978.PubMedGoogle Scholar
  31. 31.
    Raskin N: Headaches associated with organic diseases of the nervous system. Med Clin North Am 62: 459466, 1978.Google Scholar
  32. 32.
    Kennie DC, Moore JT: Management of senile dementia. Am Fam Physician 22 (6): 105–111, 1980.PubMedGoogle Scholar
  33. 33.
    Eisdorfer C, Cohen D: Diagnostic criteria for primary neuronal degeneration of the Alzheimer’s type. J Fam Pract 11 (4): 553–557, 1980.PubMedGoogle Scholar
  34. 34.
    Massachusetts Case Records: Creutzfeldt-Jakob disease. No. (45–1980)1162. N Engl J Med 303: 1162–1167, 1980.CrossRefGoogle Scholar
  35. 35.
    Brewer NS, MacCarty CS, Wellman WE: Brain abscess: a review of recent experience. Ann Intern Med 82: 57 1576, 1975.Google Scholar
  36. 36.
    Whitley RJ, et al.: Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. N Engl J Med 297 (6): 289–294, 1977.PubMedCrossRefGoogle Scholar
  37. 37.
    Richie EL: Reye’s syndrome. Fam Pract Recert 2 (10): 43–51, 1980.Google Scholar
  38. 38.
    Penry JK, Newmark ME: The use of antiepileptic drugs. Ann Intern Med 90: 207–218, 1979.PubMedCrossRefGoogle Scholar
  39. 39.
    Med Lett 21(6):25–28, 1978.Google Scholar
  40. 40.
    Opity JM: Mental retardation: Biologic aspects of concern to pediatricians. Pediatr Rev 2: 40–50, 1980.Google Scholar
  41. 41.
    Franco S, Andrews BJ: Reduction of cerebral palsy by neonatal intensive care. Pediatr Clin North Am 24: 639649, 1977.Google Scholar
  42. 42.
    Volpe JJ: Interventricular hemorrhage in premature infants. Pediatr Rev 2: 145–153, 1980.CrossRefGoogle Scholar
  43. 43.
    Haslam R: Habilitation of the handicapped child. Pediatr Clin North Am 20: 1–27, 1973.Google Scholar
  44. 44.
    Nahmias JA: The TORCH complex. Hosp Pract 9: 6572, 1974.Google Scholar
  45. 45.
    Haynes RE, Azimi PH, Cramblett HG, et al.: Clinically distinguishable syndrome caused by viruses. Curr Probl Pediatr 5: 1–48, 1975.PubMedGoogle Scholar
  46. 46.
    McCracken GH, Kaplan JM: Penicillin treatment for congenital syphilis: a critical reappraisal. JAMA 228: 855–858, 1974.PubMedCrossRefGoogle Scholar
  47. 47.
    Milunsky A: Prenatal genetic diagnosis. Pediatr Rev 1: 283–288, 1980.CrossRefGoogle Scholar
  48. 48.
    Silberberg DH: Multiple sclerosis. Postgrad Med 64 (2): 107–114, 1978.PubMedGoogle Scholar
  49. 49.
    Cook SD, Dowling PC: Multiple sclerosis and viruses: an overview. Neurology 30 (2): 80–91, 1980.PubMedCrossRefGoogle Scholar
  50. 50.
    Johnson KP: Cerebrospinal fluid and blood assays of diagnostic usefulness in multiple sclerosis. Neurology 30 (2): 106–109, 1980.PubMedCrossRefGoogle Scholar
  51. 51.
    Starr A: Sensory evoked potentials in clinical disorders of the nervous system. Annu Rev Neurosci 1: 107–127, 1978.CrossRefGoogle Scholar
  52. 52.
    Rose AS: Long-term care of patients with multiple sclerosis: a neurologist’s perspective. Neurology 30 (2): 5960, 1980.Google Scholar
  53. 53.
    Sachais BA, Logue JN, Carey MS: Baclofen, a new antispastic drug. Arch Neurol 34: 422–426, 1977.PubMedCrossRefGoogle Scholar
  54. 54.
    Dau PC, Petajan JH, Johnson KP, et al.: Plasmapheresis in multiple sclerosis: preliminary findings. Neurology 30: 1023–1028, 1980.PubMedCrossRefGoogle Scholar
  55. 55.
    Weiner HL, Dawson DM: Plasmapheresis in multiple sclerosis: preliminary study. Neurology 30:1029–1033Google Scholar
  56. 56.
    Gelbart AO, Hamilton WJ: Parkinson’s disease. Am Fam Physician 33 (6): 182–189, 1980.Google Scholar
  57. 57.
    Yahr MD: Early recognition of Parkinson’s disease. Hosp Pract 16 (7): 65–80, 1981.Google Scholar
  58. 58.
    Caine DB, Williams AC, Neophytides A, et al.: Long-term treatment of parkinsonism with bromocriptine. Lancet 1: 735–737, 1978.Google Scholar
  59. 59.
    Murray TJ: Essential tremor. Can Med Assoc 124: 1559–1565, 1981.Google Scholar
  60. 60.
    Treatment of tardive dyskinesias. Med Lett 21(8), 1979.Google Scholar
  61. 61.
    Kobayaski RM: Drug therapy for tardive dyskinesia. N Engl J Med 296 (5): 257–259, 1979.Google Scholar
  62. 62.
    Tarlov E: Percutaneous and open microsurgical techniques for relief of refractory tic douloureux. Surg Clin North Am 60 (3): 593–607, 1980.PubMedGoogle Scholar
  63. 63.
    May M: Facial paralysis: differential diagnosis and indications for surgical therapy. Clin Plastic Surg 6(3): 275 291, 1979.Google Scholar
  64. 64.
    Wolf SM, et al.: Treatment of Bell’s palsy with prednisone: a prospective randomized study. Neurology 28: 158–161, 1978.PubMedCrossRefGoogle Scholar
  65. 65.
    Burton RC, Frederic MW, Pulec JL, Rubin W: Evaluation complaints of dizziness. Patient Care 15 (11): 23–61, 1981.Google Scholar
  66. 66.
    Syringomyelia. In: Barnett HJM, Foster JB, Hudgson PO (eds.) Major Problems in Neurology, Vol. 1. Philadelphia, W.B. Saunders Co, 1973.Google Scholar
  67. 67.
    Williams B: A critical appraisal of posterior fossa sur gery for communicating syringomyelia. Brain 101: 223–250, 1978.PubMedCrossRefGoogle Scholar
  68. 68.
    Amico LL, Antel JP: Amyotrophic lateral sclerosis. Postgrad Med 70 (2): 50–61, 1981.PubMedGoogle Scholar
  69. 69.
    DeLisa JA, Mikulic MA, Miller RM, et al.: Amyotrophic lateral sclerosis: comprehensive management. Am Fam Physician 19: 137–142, 1979.PubMedGoogle Scholar
  70. 70.
    Newsum JK, Smith RM, Crocker D: Intubation for acute respiratory failure in Guillain-Barré syndrome. JAMA 242 (15): 1650–1651, 1979.PubMedCrossRefGoogle Scholar
  71. 71.
    Gashi F, Kendrick MM: Guillain-Barré syndrome. South Med J 68: 1524–1528, 1975.PubMedCrossRefGoogle Scholar
  72. 72.
    Asbury A, Fisher R, McKhann G, et al.: Guillain-Barré syndrome: is there a role for plasmapheresis? Neurology 30: 1112, 1980.PubMedCrossRefGoogle Scholar
  73. 73.
    Flaggman PD, Kelly JJ: Brachial plexus neuropathy. An electrophysiologic evaluation. Arch Neurol 37: 160–164, 1980.PubMedCrossRefGoogle Scholar
  74. 74.
    Raff MC, Asbury AK: Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. N Engl J Med 279 (1): 17–22, 1968.PubMedCrossRefGoogle Scholar
  75. 75.
    Drachman DB: Myasthenia gravis. N Engl J Med 298 (4): 136–142, 1978.PubMedCrossRefGoogle Scholar
  76. 76.
    Pinching AJ, Peters DK, Newson DJ: Remission of myasthenia gravis following plasma exchange. Lancet 2: 1373–1376, 1976.PubMedCrossRefGoogle Scholar
  77. 77.
    Bohan A, Peter JB: Polymyositis and dermatomyositis. N Engl J Med 292(7):344–347, 292 (8): 403–407, 1975.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • James A. Ferrante

There are no affiliations available

Personalised recommendations